A carregar...
A novel small-molecule inhibitor of HIV-1 entry
BACKGROUND: Antiretroviral therapy has transformed HIV-1 infection into a managed condition with near-normal life expectancy. However, a significant number of patients remain with limited therapeutic options due to HIV-1 resistance, side effects, or drug costs. Further, it is likely that current dru...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4598220/ https://ncbi.nlm.nih.gov/pubmed/26491257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S89338 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|